Peptide Synthesis Market Regional Analysis:
North America Market Insights
The peptide synthesis sector in the North America region is set to witness the largest market share of 35% by the end of the forecast period. The government and academic institutions' increasing efforts to create innovative peptide-based medicinal pharmaceuticals can be largely responsible for the market's expansion in the region. The market for peptide synthesis in North America is expanding due to the rising incidence of chronic diseases including diabetes, and cancer, as well as the rising need for peptide-based medications. For instance, according to a recent assessment by the International Diabetic Federation (IDF), 14.096 percent of persons in the North America and Caribbean (NAC) area aged 20 and older were predicted to have diabetes in 2021.
APAC Market Insights
In the Asia Pacific region, the peptide synthesis market is anticipated to grow significantly during the time period between 2026-2035. Market growth is mainly influenced due to technological advancements in peptide synthesis. The aging population in this region is expected to drive the growth of the regional peptide market. As people age, their bodies become more susceptible to chronic diseases that require special treatment. In addition, the rise of the biotechnology and biopharmaceutical sector is also expected to drive the regional growth of the market during the studied period.
